Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 577.60
-3.00 (-0.52%)
Oct 9, 2025, 1:01 PM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 130.73 billion as of October 9, 2025. Its market cap has decreased by -35.45% in one year.
Market Cap
130.73B
Enterprise Value
154.22B
Revenue
27.87B
Ranking
n/a
PE Ratio
32.12
Stock Price
577.60
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 130.73B, an increase of 2,123.33%. That is a compound annual growth rate of 11.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 130.73B | -26.14% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | 197.71B | 12.62% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,708.05B |
| Genmab | 128.83B |
| Demant | 49.50B |
| ALK-Abelló | 47.11B |
| H. Lundbeck | 43.40B |
| Zealand Pharma | 35.17B |
| Ambu A/S | 28.53B |
| Bavarian Nordic | 17.96B |